LEMAITRE VASCULAR INC's ticker is LMAT and the CUSIP is 525558201. A total of 141 filers reported holding LEMAITRE VASCULAR INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,595 | -11.6% | 1,333 | +9.2% | 0.00% | – |
| Q2 2023 | $82,124 | +26.1% | 1,221 | -3.6% | 0.00% | – |
| Q1 2023 | $65,124 | +373.3% | 1,266 | +323.4% | 0.00% | – |
| Q4 2022 | $13,760 | -68.7% | 299 | -65.8% | 0.00% | – |
| Q3 2022 | $44,000 | -88.4% | 875 | -89.5% | 0.00% | – |
| Q2 2022 | $378,000 | -43.8% | 8,295 | -42.6% | 0.00% | – |
| Q1 2022 | $672,000 | +33500.0% | 14,448 | +46506.5% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 31 | -29.5% | 0.00% | – |
| Q3 2021 | $2,000 | -33.3% | 44 | +2.3% | 0.00% | – |
| Q2 2021 | $3,000 | – | 43 | +4200.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 1 | -97.2% | 0.00% | – |
| Q4 2019 | $1,000 | – | 36 | +3500.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 1 | -99.2% | 0.00% | – |
| Q4 2018 | $3,000 | -57.1% | 130 | -27.0% | 0.00% | – |
| Q3 2018 | $7,000 | – | 178 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 350,194 | $11,724,000 | 1.96% |
| Ranger Investment Management | 699,843 | $23,431,000 | 1.64% |
| THB ASSET MANAGEMENT | 392,100 | $13,127,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 64,550 | $2,161,000 | 1.55% |
| Conestoga Capital Advisors, LLC | 1,392,591 | $46,624,000 | 1.50% |
| Summit Creek Advisors LLC | 213,761 | $7,157,000 | 1.28% |
| Biondo Investment Advisors, LLC | 107,405 | $3,603,000 | 0.91% |
| Concorde Asset Management, LLC | 21,207 | $710,000 | 0.81% |
| Capital Impact Advisors, LLC | 51,542 | $1,739,000 | 0.64% |
| Sapphire Star Partners LP | 12,290 | $412,000 | 0.42% |